Owing to islet amyloid formation not found in all T2DM patients and a limited number of studies, we cannot directly find more evidence that patients with IAPP deposition defend against localized or systematic autoimmune diseases. The gene discussed is IAPP; the disease is type 2 diabetes mellitus.